Novavax Gets First Sell Rating Since 2020. It’s Got a Covid Vaccine Problem, Analyst Says.
Novavax ‘s stock dropped Friday after it received a Sell-equivalent rating. Bank of America Securities analyst Alec Stranahan initiated coverage of Novavax (ticker: NVAX ) at an Underperform rating on…
